204 related articles for article (PubMed ID: 38643113)
1. Polar lipids modify Alzheimer's Disease pathology by reducing astrocyte pro-inflammatory signaling through platelet-activating factor receptor (PTAFR) modulation.
Hans S; Stanton JE; Sauer AK; Shiels K; Saha SK; Lordan R; Tsoupras A; Zabetakis I; Grabrucker AM
Lipids Health Dis; 2024 Apr; 23(1):113. PubMed ID: 38643113
[TBL] [Abstract][Full Text] [Related]
2. P38K and JNK pathways are induced by amyloid-β in astrocyte: Implication of MAPK pathways in astrogliosis in Alzheimer's disease.
Saha P; Guha S; Biswas SC
Mol Cell Neurosci; 2020 Oct; 108():103551. PubMed ID: 32896578
[TBL] [Abstract][Full Text] [Related]
3. Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Aβ Oligomers in Alzheimer's Disease Model.
Diniz LP; Tortelli V; Matias I; Morgado J; Bérgamo Araujo AP; Melo HM; Seixas da Silva GS; Alves-Leon SV; de Souza JM; Ferreira ST; De Felice FG; Gomes FCA
J Neurosci; 2017 Jul; 37(28):6797-6809. PubMed ID: 28607171
[TBL] [Abstract][Full Text] [Related]
4. BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides.
Zhou J; Singh N; Galske J; Hudobenko J; Hu X; Yan R
Mol Neurodegener; 2023 May; 18(1):31. PubMed ID: 37143090
[TBL] [Abstract][Full Text] [Related]
5. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.
Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM
Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920
[TBL] [Abstract][Full Text] [Related]
6. Oleanolic acid protects against cognitive decline and neuroinflammation-mediated neurotoxicity by blocking secretory phospholipase A2 IIA-activated calcium signals.
Zhang L; Xia R; Jia J; Wang L; Li K; Li Y; Zhang J
Mol Immunol; 2018 Jul; 99():95-103. PubMed ID: 29747052
[TBL] [Abstract][Full Text] [Related]
7. The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis.
Zhao J; O'Connor T; Vassar R
J Neuroinflammation; 2011 Nov; 8():150. PubMed ID: 22047170
[TBL] [Abstract][Full Text] [Related]
8. A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Aβ Clearance.
Zhang H; Chen W; Tan Z; Zhang L; Dong Z; Cui W; Zhao K; Wang H; Jing H; Cao R; Kim C; Safar JG; Xiong WC; Mei L
J Neurosci; 2020 Jul; 40(28):5347-5361. PubMed ID: 32457076
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease.
Davis N; Mota BC; Stead L; Palmer EOC; Lombardero L; Rodríguez-Puertas R; de Paola V; Barnes SJ; Sastre M
J Neuroinflammation; 2021 Mar; 18(1):73. PubMed ID: 33731156
[TBL] [Abstract][Full Text] [Related]
10. Cyclical amyloid beta-astrocyte activity induces oxidative stress in Alzheimer's disease.
Elangovan S; Holsinger RMD
Biochimie; 2020; 171-172():38-42. PubMed ID: 32061803
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology.
Stym-Popper G; Matta K; Chaigneau T; Rupra R; Demetriou A; Fouquet S; Dansokho C; Toly-Ndour C; Dorothée G
J Neuroinflammation; 2023 Mar; 20(1):64. PubMed ID: 36890536
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.
Lv J; Ma S; Zhang X; Zheng L; Ma Y; Zhao X; Lai W; Shen H; Wang Q; Ji J
J Proteomics; 2014 Oct; 110():45-58. PubMed ID: 25108202
[TBL] [Abstract][Full Text] [Related]
13. Neuronally Derived Soluble Abeta Evokes Cell-Wide Astrocytic Calcium Dysregulation in Absence of Amyloid Plaques
Kelly P; Sanchez-Mico MV; Hou SS; Whiteman S; Russ A; Hudry E; Arbel-Ornath M; Greenberg SM; Bacskai BJ
J Neurosci; 2023 Jun; 43(26):4926-4940. PubMed ID: 37236808
[TBL] [Abstract][Full Text] [Related]
14. The role of astrocytes in amyloid production and Alzheimer's disease.
Frost GR; Li YM
Open Biol; 2017 Dec; 7(12):. PubMed ID: 29237809
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles derived from astrocyte-treated with haFGF
Peng D; Wang Y; Xiao Y; Peng M; Mai W; Hu B; Jia Y; Chen H; Yang Y; Xiang Q; Su Z; Zhang Q; Huang Y
Theranostics; 2022; 12(8):3862-3881. PubMed ID: 35664060
[No Abstract] [Full Text] [Related]
16. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
[TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation in Alzheimer's Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals.
Sawikr Y; Yarla NS; Peluso I; Kamal MA; Aliev G; Bishayee A
Adv Protein Chem Struct Biol; 2017; 108():33-57. PubMed ID: 28427563
[TBL] [Abstract][Full Text] [Related]
18. A role for astrocyte-derived amyloid β peptides in the degeneration of neurons in an animal model of temporal lobe epilepsy.
Kodam A; Ourdev D; Maulik M; Hariharakrishnan J; Banerjee M; Wang Y; Kar S
Brain Pathol; 2019 Jan; 29(1):28-44. PubMed ID: 29665128
[TBL] [Abstract][Full Text] [Related]
19. The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
Mulder SD; Veerhuis R; Blankenstein MA; Nielsen HM
Exp Neurol; 2012 Jan; 233(1):373-9. PubMed ID: 22101005
[TBL] [Abstract][Full Text] [Related]
20. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
